お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書はエピジェネティック医薬品・診断薬市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートはエピジェネティック医薬品・診断薬の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界のエピジェネティック医薬品・診断薬市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートはエピジェネティック医薬品・診断薬のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別にエピジェネティック医薬品・診断薬市場を分類しています。本研究に含まれる主な企業は：Varlix Plc、Topotarget、Syndax Pharmaceuticals、Spectrum Pharmaceuticals、Promega、Novartis、Oncolys BioPharma、MDxHealth、Merck、Illumina、Epizyme、Forum Pharmaceuticals、EpiGentek、Chroma Therapeutics、Celleron Therapeutics、CellCentric、Astex Pharmaceuticals、Acetylon Pharmaceuticals、4SC AG、Eisai、Pharmacyclics

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    HDAC inhibitors
    DNMT inhibitors

用途別の市場セグメント：
    Non coding RNA’s
    Micro RNA’s
    Histone modifications
    DNA methylation

本レポートの詳細内容
世界のエピジェネティック医薬品・診断薬市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、エピジェネティック医薬品・診断薬タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業のエピジェネティック医薬品・診断薬収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のエピジェネティック医薬品・診断薬市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、エピジェネティック医薬品・診断薬市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

エピジェネティック医薬品・診断薬のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：エピジェネティック医薬品・診断薬のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：エピジェネティック医薬品・診断薬の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章エピジェネティック医薬品・診断薬企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：エピジェネティック医薬品・診断薬の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：エピジェネティック医薬品・診断薬の主要企業の概要を提供し、製品の説明と仕様、エピジェネティック医薬品・診断薬の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Market Analysis and Insights: Global Epigenetics Drugs and Diagnostic Technologies Market
The global Epigenetics Drugs and Diagnostic Technologies market is projected to grow from US$ 10740 million in 2024 to US$ 27650 million by 2030, at a Compound Annual Growth Rate (CAGR) of 17.1% during the forecast period.
The US & Canada market for Epigenetics Drugs and Diagnostic Technologies is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Epigenetics Drugs and Diagnostic Technologies is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Epigenetics Drugs and Diagnostic Technologies is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Epigenetics Drugs and Diagnostic Technologies include Varlix Plc, Topotarget, Syndax Pharmaceuticals, Spectrum Pharmaceuticals, Promega, Novartis, Oncolys BioPharma, MDxHealth and Merck, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Epigenetics Drugs and Diagnostic Technologies is widely used in various fields, such as Non coding RNA’s, Micro RNA’s, Histone modifications and DNA methylation, etc. Non coding RNA’s provides greatest supports to the Epigenetics Drugs and Diagnostic Technologies industry development. In 2023, global % revenue of Epigenetics Drugs and Diagnostic Technologies went into Non coding RNA’s filed and the proportion will reach to % in 2030. 
Report Covers:
This report presents an overview of global market for Epigenetics Drugs and Diagnostic Technologies market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Epigenetics Drugs and Diagnostic Technologies, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Epigenetics Drugs and Diagnostic Technologies, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Epigenetics Drugs and Diagnostic Technologies revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Epigenetics Drugs and Diagnostic Technologies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Epigenetics Drugs and Diagnostic Technologies revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Varlix Plc, Topotarget, Syndax Pharmaceuticals, Spectrum Pharmaceuticals, Promega, Novartis, Oncolys BioPharma, MDxHealth and Merck, etc.

Market Segmentation
By Company
    Varlix Plc
    Topotarget
    Syndax Pharmaceuticals
    Spectrum Pharmaceuticals
    Promega
    Novartis
    Oncolys BioPharma
    MDxHealth
    Merck
    Illumina
    Epizyme
    Forum Pharmaceuticals
    EpiGentek
    Chroma Therapeutics
    Celleron Therapeutics
    CellCentric
    Astex Pharmaceuticals
    Acetylon Pharmaceuticals
    4SC AG
    Eisai
    Pharmacyclics

Segment by Type
    HDAC inhibitors
    DNMT inhibitors

Segment by Application
    Non coding RNA’s
    Micro RNA’s
    Histone modifications
    DNA methylation

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Epigenetics Drugs and Diagnostic Technologies in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Epigenetics Drugs and Diagnostic Technologies companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Epigenetics Drugs and Diagnostic Technologies revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Epigenetics Drugs and Diagnostic Technologies Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of HDAC inhibitors
    Table 3. Key Players of DNMT inhibitors
    Table 4. Global Epigenetics Drugs and Diagnostic Technologies Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Epigenetics Drugs and Diagnostic Technologies Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Epigenetics Drugs and Diagnostic Technologies Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Epigenetics Drugs and Diagnostic Technologies Market Share by Region (2019-2024)
    Table 8. Global Epigenetics Drugs and Diagnostic Technologies Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Epigenetics Drugs and Diagnostic Technologies Market Share by Region (2025-2030)
    Table 10. Epigenetics Drugs and Diagnostic Technologies Market Trends
    Table 11. Epigenetics Drugs and Diagnostic Technologies Market Drivers
    Table 12. Epigenetics Drugs and Diagnostic Technologies Market Challenges
    Table 13. Epigenetics Drugs and Diagnostic Technologies Market Restraints
    Table 14. Global Epigenetics Drugs and Diagnostic Technologies Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Epigenetics Drugs and Diagnostic Technologies Revenue Share by Players (2019-2024)
    Table 16. Global Top Epigenetics Drugs and Diagnostic Technologies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epigenetics Drugs and Diagnostic Technologies as of 2023)
    Table 17. Global Epigenetics Drugs and Diagnostic Technologies Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Epigenetics Drugs and Diagnostic Technologies Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Epigenetics Drugs and Diagnostic Technologies, Headquarters and Area Served
    Table 20. Global Key Players of Epigenetics Drugs and Diagnostic Technologies, Product and Application
    Table 21. Global Key Players of Epigenetics Drugs and Diagnostic Technologies, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Epigenetics Drugs and Diagnostic Technologies Revenue Market Share by Type (2019-2024)
    Table 25. Global Epigenetics Drugs and Diagnostic Technologies Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Epigenetics Drugs and Diagnostic Technologies Revenue Market Share by Type (2025-2030)
    Table 27. Global Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Epigenetics Drugs and Diagnostic Technologies Revenue Share by Application (2019-2024)
    Table 29. Global Epigenetics Drugs and Diagnostic Technologies Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Epigenetics Drugs and Diagnostic Technologies Revenue Share by Application (2025-2030)
    Table 31. North America Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Epigenetics Drugs and Diagnostic Technologies Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Epigenetics Drugs and Diagnostic Technologies Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Epigenetics Drugs and Diagnostic Technologies Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Epigenetics Drugs and Diagnostic Technologies Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Epigenetics Drugs and Diagnostic Technologies Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Epigenetics Drugs and Diagnostic Technologies Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Varlix Plc Company Details
    Table 64. Varlix Plc Business Overview
    Table 65. Varlix Plc Epigenetics Drugs and Diagnostic Technologies Product
    Table 66. Varlix Plc Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024) & (US$ Million)
    Table 67. Varlix Plc Recent Developments
    Table 68. Topotarget Company Details
    Table 69. Topotarget Business Overview
    Table 70. Topotarget Epigenetics Drugs and Diagnostic Technologies Product
    Table 71. Topotarget Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024) & (US$ Million)
    Table 72. Topotarget Recent Developments
    Table 73. Syndax Pharmaceuticals Company Details
    Table 74. Syndax Pharmaceuticals Business Overview
    Table 75. Syndax Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Product
    Table 76. Syndax Pharmaceuticals Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024) & (US$ Million)
    Table 77. Syndax Pharmaceuticals Recent Developments
    Table 78. Spectrum Pharmaceuticals Company Details
    Table 79. Spectrum Pharmaceuticals Business Overview
    Table 80. Spectrum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Product
    Table 81. Spectrum Pharmaceuticals Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024) & (US$ Million)
    Table 82. Spectrum Pharmaceuticals Recent Developments
    Table 83. Promega Company Details
    Table 84. Promega Business Overview
    Table 85. Promega Epigenetics Drugs and Diagnostic Technologies Product
    Table 86. Promega Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024) & (US$ Million)
    Table 87. Promega Recent Developments
    Table 88. Novartis Company Details
    Table 89. Novartis Business Overview
    Table 90. Novartis Epigenetics Drugs and Diagnostic Technologies Product
    Table 91. Novartis Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024) & (US$ Million)
    Table 92. Novartis Recent Developments
    Table 93. Oncolys BioPharma Company Details
    Table 94. Oncolys BioPharma Business Overview
    Table 95. Oncolys BioPharma Epigenetics Drugs and Diagnostic Technologies Product
    Table 96. Oncolys BioPharma Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024) & (US$ Million)
    Table 97. Oncolys BioPharma Recent Developments
    Table 98. MDxHealth Company Details
    Table 99. MDxHealth Business Overview
    Table 100. MDxHealth Epigenetics Drugs and Diagnostic Technologies Product
    Table 101. MDxHealth Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024) & (US$ Million)
    Table 102. MDxHealth Recent Developments
    Table 103. Merck Company Details
    Table 104. Merck Business Overview
    Table 105. Merck Epigenetics Drugs and Diagnostic Technologies Product
    Table 106. Merck Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024) & (US$ Million)
    Table 107. Merck Recent Developments
    Table 108. Illumina Company Details
    Table 109. Illumina Business Overview
    Table 110. Illumina Epigenetics Drugs and Diagnostic Technologies Product
    Table 111. Illumina Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024) & (US$ Million)
    Table 112. Illumina Recent Developments
    Table 113. Epizyme Company Details
    Table 114. Epizyme Business Overview
    Table 115. Epizyme Epigenetics Drugs and Diagnostic Technologies Product
    Table 116. Epizyme Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024) & (US$ Million)
    Table 117. Epizyme Recent Developments
    Table 118. Forum Pharmaceuticals Company Details
    Table 119. Forum Pharmaceuticals Business Overview
    Table 120. Forum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Product
    Table 121. Forum Pharmaceuticals Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024) & (US$ Million)
    Table 122. Forum Pharmaceuticals Recent Developments
    Table 123. EpiGentek Company Details
    Table 124. EpiGentek Business Overview
    Table 125. EpiGentek Epigenetics Drugs and Diagnostic Technologies Product
    Table 126. EpiGentek Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024) & (US$ Million)
    Table 127. EpiGentek Recent Developments
    Table 128. Chroma Therapeutics Company Details
    Table 129. Chroma Therapeutics Business Overview
    Table 130. Chroma Therapeutics Epigenetics Drugs and Diagnostic Technologies Product
    Table 131. Chroma Therapeutics Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024) & (US$ Million)
    Table 132. Chroma Therapeutics Recent Developments
    Table 133. Celleron Therapeutics Company Details
    Table 134. Celleron Therapeutics Business Overview
    Table 135. Celleron Therapeutics Epigenetics Drugs and Diagnostic Technologies Product
    Table 136. Celleron Therapeutics Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024) & (US$ Million)
    Table 137. Celleron Therapeutics Recent Developments
    Table 138. CellCentric Company Details
    Table 139. CellCentric Business Overview
    Table 140. CellCentric Epigenetics Drugs and Diagnostic Technologies Product
    Table 141. CellCentric Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024) & (US$ Million)
    Table 142. CellCentric Recent Developments
    Table 143. Astex Pharmaceuticals Company Details
    Table 144. Astex Pharmaceuticals Business Overview
    Table 145. Astex Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Product
    Table 146. Astex Pharmaceuticals Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024) & (US$ Million)
    Table 147. Astex Pharmaceuticals Recent Developments
    Table 148. Acetylon Pharmaceuticals Company Details
    Table 149. Acetylon Pharmaceuticals Business Overview
    Table 150. Acetylon Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Product
    Table 151. Acetylon Pharmaceuticals Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024) & (US$ Million)
    Table 152. Acetylon Pharmaceuticals Recent Developments
    Table 153. 4SC AG Company Details
    Table 154. 4SC AG Business Overview
    Table 155. 4SC AG Epigenetics Drugs and Diagnostic Technologies Product
    Table 156. 4SC AG Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024) & (US$ Million)
    Table 157. 4SC AG Recent Developments
    Table 158. Eisai Company Details
    Table 159. Eisai Business Overview
    Table 160. Eisai Epigenetics Drugs and Diagnostic Technologies Product
    Table 161. Eisai Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024) & (US$ Million)
    Table 162. Eisai Recent Developments
    Table 163. Pharmacyclics Company Details
    Table 164. Pharmacyclics Business Overview
    Table 165. Pharmacyclics Epigenetics Drugs and Diagnostic Technologies Product
    Table 166. Pharmacyclics Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024) & (US$ Million)
    Table 167. Pharmacyclics Recent Developments
    Table 168. Research Programs/Design for This Report
    Table 169. Key Data Information from Secondary Sources
    Table 170. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Epigenetics Drugs and Diagnostic Technologies Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Epigenetics Drugs and Diagnostic Technologies Market Share by Type: 2023 VS 2030
    Figure 3. HDAC inhibitors Features
    Figure 4. DNMT inhibitors Features
    Figure 5. Global Epigenetics Drugs and Diagnostic Technologies Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Epigenetics Drugs and Diagnostic Technologies Market Share by Application: 2023 VS 2030
    Figure 7. Non coding RNA’s Case Studies
    Figure 8. Micro RNA’s Case Studies
    Figure 9. Histone modifications Case Studies
    Figure 10. DNA methylation Case Studies
    Figure 11. Epigenetics Drugs and Diagnostic Technologies Report Years Considered
    Figure 12. Global Epigenetics Drugs and Diagnostic Technologies Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Epigenetics Drugs and Diagnostic Technologies Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Epigenetics Drugs and Diagnostic Technologies Market Share by Region: 2023 VS 2030
    Figure 15. Global Epigenetics Drugs and Diagnostic Technologies Market Share by Players in 2023
    Figure 16. Global Top Epigenetics Drugs and Diagnostic Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epigenetics Drugs and Diagnostic Technologies as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Epigenetics Drugs and Diagnostic Technologies Revenue in 2023
    Figure 18. North America Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Epigenetics Drugs and Diagnostic Technologies Market Share by Type (2019-2030)
    Figure 20. North America Epigenetics Drugs and Diagnostic Technologies Market Share by Application (2019-2030)
    Figure 21. North America Epigenetics Drugs and Diagnostic Technologies Market Share by Country (2019-2030)
    Figure 22. United States Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Epigenetics Drugs and Diagnostic Technologies Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Epigenetics Drugs and Diagnostic Technologies Market Share by Type (2019-2030)
    Figure 26. Europe Epigenetics Drugs and Diagnostic Technologies Market Share by Application (2019-2030)
    Figure 27. Europe Epigenetics Drugs and Diagnostic Technologies Market Share by Country (2019-2030)
    Figure 28. Germany Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Epigenetics Drugs and Diagnostic Technologies Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Epigenetics Drugs and Diagnostic Technologies Market Share by Type (2019-2030)
    Figure 36. China Epigenetics Drugs and Diagnostic Technologies Market Share by Application (2019-2030)
    Figure 37. Asia Epigenetics Drugs and Diagnostic Technologies Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Epigenetics Drugs and Diagnostic Technologies Market Share by Type (2019-2030)
    Figure 39. Asia Epigenetics Drugs and Diagnostic Technologies Market Share by Application (2019-2030)
    Figure 40. Asia Epigenetics Drugs and Diagnostic Technologies Market Share by Region (2019-2030)
    Figure 41. Japan Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Epigenetics Drugs and Diagnostic Technologies Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Epigenetics Drugs and Diagnostic Technologies Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Epigenetics Drugs and Diagnostic Technologies Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Epigenetics Drugs and Diagnostic Technologies Market Share by Country (2019-2030)
    Figure 51. Brazil Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Varlix Plc Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024)
    Figure 58. Topotarget Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024)
    Figure 59. Syndax Pharmaceuticals Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024)
    Figure 60. Spectrum Pharmaceuticals Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024)
    Figure 61. Promega Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024)
    Figure 62. Novartis Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024)
    Figure 63. Oncolys BioPharma Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024)
    Figure 64. MDxHealth Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024)
    Figure 65. Merck Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024)
    Figure 66. Illumina Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024)
    Figure 67. Epizyme Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024)
    Figure 68. Forum Pharmaceuticals Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024)
    Figure 69. EpiGentek Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024)
    Figure 70. Chroma Therapeutics Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024)
    Figure 71. Celleron Therapeutics Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024)
    Figure 72. CellCentric Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024)
    Figure 73. Astex Pharmaceuticals Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024)
    Figure 74. Acetylon Pharmaceuticals Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024)
    Figure 75. 4SC AG Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024)
    Figure 76. Eisai Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024)
    Figure 77. Pharmacyclics Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2019-2024)
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed